We are live on ! Find out more
RPRX icon

Royalty Pharma
RPRX

378 hedge funds and large institutions have $8.35B invested in Royalty Pharma in 2024 Q2 according to their latest regulatory filings, with 60 funds opening new positions, 141 increasing their positions, 127 reducing their positions, and 56 closing their positions.

New
Increased
Maintained
Reduced
Closed

222% more call options, than puts

Call options by funds: $13.5M | Put options by funds: $4.19M

11% more repeat investments, than reductions

Existing positions increased: 141 | Existing positions reduced: 127

1.94% more ownership

Funds ownership: 68.15% → 70.09% (+1.9%)

7% more first-time investments, than exits

New positions opened: 60 | Existing positions closed: 56

0% more funds holding

Funds holding: 378 → 378 (0)

0% more funds holding in top 10

Funds holding in top 10: 7 → 7 (0)

10% less capital invested

Capital invested by funds: $9.24B → $8.35B (-$885M)

Holders
378
Holders Change
–
Holders Change %
0%
% of All Funds
5.46%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
60
Increased
141
Reduced
127
Closed
56
Calls
$13.5M
Puts
$4.19M
Net Calls
+$9.31M
Net Calls Change
+$4.69M

Top Buyers

1
Swedbank
Swedbank
Sweden
+$300M
2
BlackRock
BlackRock
New York
+$50.2M
3
BGIM
Brandywine Global Investment Management
Pennsylvania
+$45.4M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$29.5M
5
Invesco
Invesco
Georgia
+$29.5M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$159M
2
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance)
Ontario, Canada
-$81.4M
3
Millennium Management
Millennium Management
New York
-$64.2M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$15.8M
5
CSS
Cubist Systematic Strategies
Connecticut
-$14.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
FAF
101
Första AP-fonden
Sweden
$6.22M +$3.8M +137,100 +139%
Treasurer of the State of North Carolina
102
Treasurer of the State of North Carolina
North Carolina
$6.1M +$1.54M +55,404 +32%
HKAM
103
Horizon Kinetics Asset Management
New York
$6.03M +$790K +28,496 +14%
SF
104
Synovus Financial
Georgia
$5.87M +$3.1M +111,918 +101%
Mitsubishi UFJ Asset Management
105
Mitsubishi UFJ Asset Management
Japan
$5.71M – – –
UIM
106
USS Investment Management
United Kingdom
$5.68M +$277K +10,008 +5%
Allianz Asset Management
107
Allianz Asset Management
Germany
$5.43M +$1.6M +57,870 +39%
State of Wisconsin Investment Board
108
State of Wisconsin Investment Board
Wisconsin
$5.31M -$31.9K -1,149 -0.6%
OMC
109
Overbrook Management Corp
New York
$5.28M -$248K -8,937 -4%
Korea Investment Corp
110
Korea Investment Corp
South Korea
$5.2M -$145K -5,218 -3%
HighTower Advisors
111
HighTower Advisors
Illinois
$5.17M -$782K -28,212 -13%
MNA
112
Manning & Napier Advisors
New York
$5.16M +$5.43M +195,853 New
Thrivent Financial for Lutherans
113
Thrivent Financial for Lutherans
Minnesota
$4.59M +$4.28M +154,408 +778%
Ensign Peak Advisors
114
Ensign Peak Advisors
Utah
$4.53M -$160K -5,771 -3%
Kovitz Investment Group Partners
115
Kovitz Investment Group Partners
Illinois
$4.47M +$1.71M +61,661 +57%
Zurich Cantonal Bank
116
Zurich Cantonal Bank
Switzerland
$4.37M -$214K -7,727 -5%
Ohio Public Employees Retirement System (OPERS)
117
Ohio Public Employees Retirement System (OPERS)
Ohio
$4.32M +$204K +7,375 +5%
PCP
118
Pacific Capital Partners
$4.29M – – –
CM
119
CM Management
Florida
$4.22M – – –
Bank of Montreal
120
Bank of Montreal
Ontario, Canada
$4.2M -$899K -32,429 -17%
Royal London Asset Management
121
Royal London Asset Management
United Kingdom
$4.11M -$5.09M -183,688 -54%
State of New Jersey Common Pension Fund D
122
State of New Jersey Common Pension Fund D
New Jersey
$4.05M -$1.35M -48,599 -24%
GC
123
Guggenheim Capital
Illinois
$3.98M +$757K +27,296 +22%
MA
124
Menlo Advisors
California
$3.9M +$4.1M +147,885 New
HWM
125
Hohimer Wealth Management
Washington
$3.79M +$3.99M +143,912 New
3 4
5
6 7

RPRX Hedge Fund Activity: Q2 2024 in Review

378 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Royalty Pharma (RPRX) for Q2 2024, worth a combined $8.35B — down 9.6% from $9.24B a quarter earlier.

Buyers outnumbered sellers: 60 funds opened new RPRX positions and 56 closed out — a net gain of 4 holders — while 141 added to existing stakes and 127 trimmed.

The largest buyer was Swedbank, opening a new position worth an estimated $300M. The largest seller was Fidelity Investments, cutting an estimated $159M.

  • 378 institutional investors held Royalty Pharma (RPRX) as of Q2 2024, unchanged from Q1 2024.
  • Funds reported $8.35B of Royalty Pharma stock for Q2 2024, down 9.6% quarter-over-quarter.
  • 60 funds opened new Royalty Pharma positions in Q2 2024 and 56 closed out, a net change of +4 holders.
  • The largest Royalty Pharma buyer in Q2 2024 was Swedbank, an estimated $300M added.
  • The largest Royalty Pharma seller in Q2 2024 was Fidelity Investments, an estimated $159M sold.

Based on aggregated 13F filings for Q2 2024.